CRT Pioneer Fund

CRT Pioneer Fund is an investment vehicle focused on early drug discovery projects in oncology. It supports novel therapeutic candidates, aiming to progress them through initial clinical stages, typically up to Phase 1 trials. The fund’s strategy de-risks drug concepts, preparing them for out-licensing to pharmaceutical partners, bridging research to clinical application.

The Cancer Research Technology Pioneer Fund (CPF) was established by Cancer Research Technology (CRT), the commercialization arm of Cancer Research UK. It provides essential early-stage capital and expertise for promising cancer therapies. Its creation addresses a critical funding gap, supporting Cancer Research UK’s mission to accelerate scientific discoveries into patient treatments.

The fund primarily serves academic research institutions and emerging biotechnology firms engaged in cancer drug discovery. By offering financial backing and strategic guidance, CRT Pioneer Fund enables these entities to advance projects into early human trials. Its vision is to accelerate breakthrough cancer treatments, translating scientific discoveries into vital therapeutic options for patients.